Advances in tetrahydropyrido[1,2-a]isoindolone (valmerins) series: Potent glycogen synthase kinase 3 and cyclin dependent kinase 5 inhibitors.

Abstract : An efficient synthetic strategy was developed to modulate the structure of the tetrahydropyridine isoindolone (Valmerin) skeleton. A library of more than 30 novel final structures was generated. Biological activities on CDK5 and GSK3 as well as cellular effects on cancer cell lines were measured for each novel compound. Additionally docking studies were performed to support medicinal chemistry efforts. A strong GSK3/CDK5 dual inhibitor (38, IC50 GSK3/CDK5 32/84 nM) was obtained. A set of highly selective GSK3 inhibitors was synthesized by fine-tuning structural modifications (29 IC50 GSK3/CDK5 32/320 nM). Antiproliferative effects on cells were correlated with the in vitro kinase activities and the best effects were obtained with lung and colon cell lines.
Liste complète des métadonnées

Cited literature [27 references]  Display  Hide  Download

https://hal.archives-ouvertes.fr/hal-01212495
Contributor : Stéphanie Bonnefoy <>
Submitted on : Thursday, November 19, 2015 - 3:06:32 PM
Last modification on : Monday, April 1, 2019 - 9:42:23 AM

File

Advances in Tetrahydropyrido.p...
Files produced by the author(s)

Identifiers

Citation

Rajâa Boulahjar, Aziz Ouach, Stéphane Bourg, Pascal Bonnet, Olivier Lozach, et al.. Advances in tetrahydropyrido[1,2-a]isoindolone (valmerins) series: Potent glycogen synthase kinase 3 and cyclin dependent kinase 5 inhibitors.. European Journal of Medicinal Chemistry, Elsevier, 2015, 101, pp.274-287. ⟨10.1016/j.ejmech.2015.06.046⟩. ⟨hal-01212495⟩

Share

Metrics

Record views

769

Files downloads

214